Real-time enrollment status for this pancreatic ductal adenocarcinoma clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 4:10 PM UTC
| NCT Number | NCT06673017 |
| Recruiting Status | Recruiting |
| Condition | Pancreatic Ductal Adenocarcinoma |
| Phase | PHASE1 |
| Target Enrollment | 26 participants |
| Active Locations | 8 sites in the US |
| Sponsor | PanTher Therapeutics |
| Last Updated on CT.gov | October 8, 2026 (4 days ago) |
As of October 12, 2026: Clinical trial NCT06673017 is currently recruiting participants. This phase1 study for pancreatic ductal adenocarcinoma is actively seeking new participants at 8 locations across the United States. The study is sponsored by PanTher Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06673017 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 8 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06673017 was last updated 4 days ago (October 8, 2026). HelloStudys verifies this status automatically.